Cigarette Smoke Induces an Unfolded Protein Response in the Human Lung: a Proteomic Approach
Overview
Molecular Biology
Affiliations
Cigarette smoking, which exposes the lung to high concentrations of reactive oxidant species (ROS) is the major risk factor for chronic obstructive pulmonary disease (COPD). Recent studies indicate that ROS interfere with protein folding in the endoplasmic reticulum and elicit a compensatory response termed the "unfolded protein response" (UPR). The importance of the UPR lies in its ability to alter expression of a variety of genes involved in antioxidant defense, inflammation, energy metabolism, protein synthesis, apoptosis, and cell cycle regulation. The present study used comparative proteomic technology to test the hypothesis that chronic cigarette smoking induces a UPR in the human lung. Studies were performed on lung tissue samples obtained from three groups of human subjects: nonsmokers, chronic cigarette smokers, and ex-smokers. Proteomes of lung samples from chronic cigarette smokers demonstrated 26 differentially expressed proteins (20 were up-regulated, 5 were down-regulated, and 1 was detected only in the smoking group) compared with nonsmokers. Several UPR proteins were up-regulated in smokers compared with nonsmokers and ex-smokers, including the chaperones, glucose-regulated protein 78 (GRP78) and calreticulin; a foldase, protein disulfide isomerase (PDI); and enzymes involved in antioxidant defense. In cultured human airway epithelial cells, GRP78 and the UPR-regulated basic leucine zipper, transcription factors, ATF4 and Nrf2, which enhance expression of important anti-oxidant genes, increased rapidly (< 24 h) with cigarette smoke extract. These data indicate that cigarette smoke induces a UPR response in the human lung that is rapid in onset, concentration dependent, and at least partially reversible with smoking cessation. We speculate that activation of a UPR by cigarette smoke may protect the lung from oxidant injury and the development of COPD.
Pomella S, Melaiu O, Cifaldi L, Bei R, Gargari M, Campanella V Int J Mol Sci. 2024; 25(16).
PMID: 39201614 PMC: 11354375. DOI: 10.3390/ijms25168929.
Zhao J, Han M, Tian Y, Zhao P, Liu X, Dong H Curr Pharm Biotechnol. 2023; 25(11):1466-1477.
PMID: 37921125 DOI: 10.2174/0113892010257526231019143524.
Yu Y, Yang A, He X, Wu B, Wu Y, Li Y J Inflamm (Lond). 2023; 20(1):36.
PMID: 37915073 PMC: 10621191. DOI: 10.1186/s12950-023-00361-y.
Molecular Impact of Conventional and Electronic Cigarettes on Pulmonary Surfactant.
Garavaglia M, Bodega F, Porta C, Milzani A, Sironi C, Dalle-Donne I Int J Mol Sci. 2023; 24(14).
PMID: 37511463 PMC: 10380520. DOI: 10.3390/ijms241411702.
Al Zaidi M, Marggraf V, Repges E, Nickenig G, Skowasch D, Aksoy A Cell Stress Chaperones. 2023; 28(3):333-341.
PMID: 37020080 PMC: 10167071. DOI: 10.1007/s12192-023-01341-0.